カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の抗線維症薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Antifibrotic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19145）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19145
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の抗線維症薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

抗線維症薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の抗線維症薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

抗線維症薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・内服、注射、外用

用途別セグメントは次のように区分されます。
・病院 調剤薬局、総合調剤薬局、オンライン調剤薬局

世界の抗線維症薬市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Novartis、Sanofi、Merck、Roche、Bayer、Boehringer Ingelheim、Bristol-Myers Squibb

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、抗線維症薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な抗線維症薬メーカーの企業概要、2019年～2022年までの抗線維症薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な抗線維症薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別抗線維症薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの抗線維症薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での抗線維症薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および抗線維症薬の産業チェーンを掲載しています。
・第13、14、15章では、抗線維症薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 抗線維症薬の概要
- 種類別分析（2017年vs2021年vs2028年）：内服、注射、外用
- 用途別分析（2017年vs2021年vs2028年）：病院 調剤薬局、総合調剤薬局、オンライン調剤薬局
- 世界の抗線維症薬市場規模・予測
- 世界の抗線維症薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer、Novartis、Sanofi、Merck、Roche、Bayer、Boehringer Ingelheim、Bristol-Myers Squibb
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：内服、注射、外用
・用途別分析2017年-2028年：病院 調剤薬局、総合調剤薬局、オンライン調剤薬局
・抗線維症薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・抗線維症薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・抗線維症薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・抗線維症薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・抗線維症薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Antifibrotic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antifibrotic Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals Pharmacies accounting for % of the Antifibrotic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antifibrotic Drugs include Pfizer, Novartis, Sanofi, Merck, and Roche, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antifibrotic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injectable
Topical
Market segment by Application can be divided into
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Antifibrotic Drugs market are listed below:
Pfizer
Novartis
Sanofi
Merck
Roche
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antifibrotic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antifibrotic Drugs, with price, sales, revenue and global market share of Antifibrotic Drugs from 2019 to 2022.
Chapter 3, the Antifibrotic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antifibrotic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antifibrotic Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antifibrotic Drugs.
Chapter 13, 14, and 15, to describe Antifibrotic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Antifibrotic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antifibrotic Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral
1.2.3 Injectable
1.2.4 Topical
1.3 Market Analysis by Application
1.3.1 Overview: Global Antifibrotic Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Antifibrotic Drugs Market Size & Forecast
1.4.1 Global Antifibrotic Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antifibrotic Drugs Sales in Volume (2017-2028)
1.4.3 Global Antifibrotic Drugs Price (2017-2028)
1.5 Global Antifibrotic Drugs Production Capacity Analysis
1.5.1 Global Antifibrotic Drugs Total Production Capacity (2017-2028)
1.5.2 Global Antifibrotic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antifibrotic Drugs Market Drivers
1.6.2 Antifibrotic Drugs Market Restraints
1.6.3 Antifibrotic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Antifibrotic Drugs Product and Services
2.1.4 Pfizer Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Antifibrotic Drugs Product and Services
2.2.4 Novartis Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Antifibrotic Drugs Product and Services
2.3.4 Sanofi Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Antifibrotic Drugs Product and Services
2.4.4 Merck Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Antifibrotic Drugs Product and Services
2.5.4 Roche Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer Antifibrotic Drugs Product and Services
2.6.4 Bayer Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business
2.7.3 Boehringer Ingelheim Antifibrotic Drugs Product and Services
2.7.4 Boehringer Ingelheim Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Antifibrotic Drugs Product and Services
2.8.4 Bristol-Myers Squibb Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antifibrotic Drugs Breakdown Data by Manufacturer
3.1 Global Antifibrotic Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antifibrotic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antifibrotic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Antifibrotic Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Antifibrotic Drugs Manufacturer Market Share in 2021
3.5 Global Antifibrotic Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antifibrotic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antifibrotic Drugs Market Size by Region
4.1.1 Global Antifibrotic Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Antifibrotic Drugs Revenue by Region (2017-2028)
4.2 North America Antifibrotic Drugs Revenue (2017-2028)
4.3 Europe Antifibrotic Drugs Revenue (2017-2028)
4.4 Asia-Pacific Antifibrotic Drugs Revenue (2017-2028)
4.5 South America Antifibrotic Drugs Revenue (2017-2028)
4.6 Middle East and Africa Antifibrotic Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antifibrotic Drugs Sales in Volume by Type (2017-2028)
5.2 Global Antifibrotic Drugs Revenue by Type (2017-2028)
5.3 Global Antifibrotic Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antifibrotic Drugs Sales in Volume by Application (2017-2028)
6.2 Global Antifibrotic Drugs Revenue by Application (2017-2028)
6.3 Global Antifibrotic Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antifibrotic Drugs Sales by Type (2017-2028)
7.2 North America Antifibrotic Drugs Sales by Application (2017-2028)
7.3 North America Antifibrotic Drugs Market Size by Country
7.3.1 North America Antifibrotic Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Antifibrotic Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antifibrotic Drugs Sales by Type (2017-2028)
8.2 Europe Antifibrotic Drugs Sales by Application (2017-2028)
8.3 Europe Antifibrotic Drugs Market Size by Country
8.3.1 Europe Antifibrotic Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Antifibrotic Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antifibrotic Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Antifibrotic Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Antifibrotic Drugs Market Size by Region
9.3.1 Asia-Pacific Antifibrotic Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antifibrotic Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antifibrotic Drugs Sales by Type (2017-2028)
10.2 South America Antifibrotic Drugs Sales by Application (2017-2028)
10.3 South America Antifibrotic Drugs Market Size by Country
10.3.1 South America Antifibrotic Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Antifibrotic Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antifibrotic Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Antifibrotic Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Antifibrotic Drugs Market Size by Country
11.3.1 Middle East & Africa Antifibrotic Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antifibrotic Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antifibrotic Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antifibrotic Drugs
12.3 Antifibrotic Drugs Production Process
12.4 Antifibrotic Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antifibrotic Drugs Typical Distributors
13.3 Antifibrotic Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Antifibrotic Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Antifibrotic Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Antifibrotic Drugs Product and Services
Table 6. Pfizer Antifibrotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Antifibrotic Drugs Product and Services
Table 10. Novartis Antifibrotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Antifibrotic Drugs Product and Services
Table 14. Sanofi Antifibrotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Antifibrotic Drugs Product and Services
Table 18. Merck Antifibrotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Roche Basic Information, Manufacturing Base and Competitors
Table 20. Roche Major Business
Table 21. Roche Antifibrotic Drugs Product and Services
Table 22. Roche Antifibrotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bayer Basic Information, Manufacturing Base and Competitors
Table 24. Bayer Major Business
Table 25. Bayer Antifibrotic Drugs Product and Services
Table 26. Bayer Antifibrotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 28. Boehringer Ingelheim Major Business
Table 29. Boehringer Ingelheim Antifibrotic Drugs Product and Services
Table 30. Boehringer Ingelheim Antifibrotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 32. Bristol-Myers Squibb Major Business
Table 33. Bristol-Myers Squibb Antifibrotic Drugs Product and Services
Table 34. Bristol-Myers Squibb Antifibrotic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Antifibrotic Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Antifibrotic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Antifibrotic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Antifibrotic Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Antifibrotic Drugs Production Site of Key Manufacturer
Table 40. Antifibrotic Drugs New Entrant and Capacity Expansion Plans
Table 41. Antifibrotic Drugs Mergers & Acquisitions in the Past Five Years
Table 42. Global Antifibrotic Drugs Sales by Region (2017-2022) & (K Units)
Table 43. Global Antifibrotic Drugs Sales by Region (2023-2028) & (K Units)
Table 44. Global Antifibrotic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Antifibrotic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Antifibrotic Drugs Sales by Type (2017-2022) & (K Units)
Table 47. Global Antifibrotic Drugs Sales by Type (2023-2028) & (K Units)
Table 48. Global Antifibrotic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Antifibrotic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Antifibrotic Drugs Price by Type (2017-2022) & (USD/Unit)
Table 51. Global Antifibrotic Drugs Price by Type (2023-2028) & (USD/Unit)
Table 52. Global Antifibrotic Drugs Sales by Application (2017-2022) & (K Units)
Table 53. Global Antifibrotic Drugs Sales by Application (2023-2028) & (K Units)
Table 54. Global Antifibrotic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Antifibrotic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Antifibrotic Drugs Price by Application (2017-2022) & (USD/Unit)
Table 57. Global Antifibrotic Drugs Price by Application (2023-2028) & (USD/Unit)
Table 58. North America Antifibrotic Drugs Sales by Country (2017-2022) & (K Units)
Table 59. North America Antifibrotic Drugs Sales by Country (2023-2028) & (K Units)
Table 60. North America Antifibrotic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Antifibrotic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Antifibrotic Drugs Sales by Type (2017-2022) & (K Units)
Table 63. North America Antifibrotic Drugs Sales by Type (2023-2028) & (K Units)
Table 64. North America Antifibrotic Drugs Sales by Application (2017-2022) & (K Units)
Table 65. North America Antifibrotic Drugs Sales by Application (2023-2028) & (K Units)
Table 66. Europe Antifibrotic Drugs Sales by Country (2017-2022) & (K Units)
Table 67. Europe Antifibrotic Drugs Sales by Country (2023-2028) & (K Units)
Table 68. Europe Antifibrotic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Antifibrotic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Antifibrotic Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Europe Antifibrotic Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Europe Antifibrotic Drugs Sales by Application (2017-2022) & (K Units)
Table 73. Europe Antifibrotic Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Antifibrotic Drugs Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Antifibrotic Drugs Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Antifibrotic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Antifibrotic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Antifibrotic Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Antifibrotic Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Antifibrotic Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Antifibrotic Drugs Sales by Application (2023-2028) & (K Units)
Table 82. South America Antifibrotic Drugs Sales by Country (2017-2022) & (K Units)
Table 83. South America Antifibrotic Drugs Sales by Country (2023-2028) & (K Units)
Table 84. South America Antifibrotic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Antifibrotic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Antifibrotic Drugs Sales by Type (2017-2022) & (K Units)
Table 87. South America Antifibrotic Drugs Sales by Type (2023-2028) & (K Units)
Table 88. South America Antifibrotic Drugs Sales by Application (2017-2022) & (K Units)
Table 89. South America Antifibrotic Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Antifibrotic Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Antifibrotic Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Antifibrotic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Antifibrotic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Antifibrotic Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Antifibrotic Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Antifibrotic Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Antifibrotic Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Antifibrotic Drugs Raw Material
Table 99. Key Manufacturers of Antifibrotic Drugs Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Antifibrotic Drugs Typical Distributors
Table 103. Antifibrotic Drugs Typical Customers
List of Figures
Figure 1. Antifibrotic Drugs Picture
Figure 2. Global Antifibrotic Drugs Revenue Market Share by Type in 2021
Figure 3. Oral
Figure 4. Injectable
Figure 5. Topical
Figure 6. Global Antifibrotic Drugs Revenue Market Share by Application in 2021
Figure 7. Hospitals Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Global Antifibrotic Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Antifibrotic Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Antifibrotic Drugs Sales (2017-2028) & (K Units)
Figure 13. Global Antifibrotic Drugs Price (2017-2028) & (USD/Unit)
Figure 14. Global Antifibrotic Drugs Production Capacity (2017-2028) & (K Units)
Figure 15. Global Antifibrotic Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Antifibrotic Drugs Market Drivers
Figure 17. Antifibrotic Drugs Market Restraints
Figure 18. Antifibrotic Drugs Market Trends
Figure 19. Global Antifibrotic Drugs Sales Market Share by Manufacturer in 2021
Figure 20. Global Antifibrotic Drugs Revenue Market Share by Manufacturer in 2021
Figure 21. Antifibrotic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Antifibrotic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Antifibrotic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Antifibrotic Drugs Sales Market Share by Region (2017-2028)
Figure 25. Global Antifibrotic Drugs Revenue Market Share by Region (2017-2028)
Figure 26. North America Antifibrotic Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Europe Antifibrotic Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Antifibrotic Drugs Revenue (2017-2028) & (USD Million)
Figure 29. South America Antifibrotic Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Antifibrotic Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Global Antifibrotic Drugs Sales Market Share by Type (2017-2028)
Figure 32. Global Antifibrotic Drugs Revenue Market Share by Type (2017-2028)
Figure 33. Global Antifibrotic Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Antifibrotic Drugs Sales Market Share by Application (2017-2028)
Figure 35. Global Antifibrotic Drugs Revenue Market Share by Application (2017-2028)
Figure 36. Global Antifibrotic Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Antifibrotic Drugs Sales Market Share by Type (2017-2028)
Figure 38. North America Antifibrotic Drugs Sales Market Share by Application (2017-2028)
Figure 39. North America Antifibrotic Drugs Sales Market Share by Country (2017-2028)
Figure 40. North America Antifibrotic Drugs Revenue Market Share by Country (2017-2028)
Figure 41. United States Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Antifibrotic Drugs Sales Market Share by Type (2017-2028)
Figure 45. Europe Antifibrotic Drugs Sales Market Share by Application (2017-2028)
Figure 46. Europe Antifibrotic Drugs Sales Market Share by Country (2017-2028)
Figure 47. Europe Antifibrotic Drugs Revenue Market Share by Country (2017-2028)
Figure 48. Germany Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Antifibrotic Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Antifibrotic Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Antifibrotic Drugs Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Antifibrotic Drugs Revenue Market Share by Region (2017-2028)
Figure 57. China Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Antifibrotic Drugs Sales Market Share by Type (2017-2028)
Figure 64. South America Antifibrotic Drugs Sales Market Share by Application (2017-2028)
Figure 65. South America Antifibrotic Drugs Sales Market Share by Country (2017-2028)
Figure 66. South America Antifibrotic Drugs Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Antifibrotic Drugs Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Antifibrotic Drugs Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Antifibrotic Drugs Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Antifibrotic Drugs Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Antifibrotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Antifibrotic Drugs in 2021
Figure 78. Manufacturing Process Analysis of Antifibrotic Drugs
Figure 79. Antifibrotic Drugs Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
  • 世界のエクセナチド薬物市場2022年：市場規模予測（～2028年）
  • 世界のペガスパルガーゼ薬物市場2022年：市場規模予測（～2028年）
  • 世界のリロナセプト薬物市場2022年：市場規模予測（～2028年）
  • 世界のブリナツモマブ治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19145 )"世界の抗線維症薬市場2022年：市場規模予測（～2028年）" (英文：Global Antifibrotic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。